rs151073358
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_181332.3(NLGN4X):āc.897A>Gā(p.Ile299Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,210,157 control chromosomes in the GnomAD database, including 16 homozygotes. There are 371 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_181332.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN4X | NM_181332.3 | c.897A>G | p.Ile299Met | missense_variant | 5/6 | ENST00000381095.8 | NP_851849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN4X | ENST00000381095.8 | c.897A>G | p.Ile299Met | missense_variant | 5/6 | 1 | NM_181332.3 | ENSP00000370485.3 |
Frequencies
GnomAD3 genomes AF: 0.00687 AC: 768AN: 111853Hom.: 8 Cov.: 23 AF XY: 0.00502 AC XY: 171AN XY: 34033
GnomAD3 exomes AF: 0.00180 AC: 331AN: 183495Hom.: 1 AF XY: 0.000927 AC XY: 63AN XY: 67935
GnomAD4 exome AF: 0.000665 AC: 730AN: 1098251Hom.: 8 Cov.: 33 AF XY: 0.000550 AC XY: 200AN XY: 363607
GnomAD4 genome AF: 0.00687 AC: 769AN: 111906Hom.: 8 Cov.: 23 AF XY: 0.00502 AC XY: 171AN XY: 34096
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 18, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at